COIN vs DMAC · P/E 64, rev $7.18B vs $157.4M cap
Coinbase Global Inc (COIN) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
DMAC does not have a complete income-statement cache yet.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the COIN and DMAC stock pages for the full models.
Not investment advice.